Mitchell Sanders, PhDChief Scientific Officer

    Mitchell Sanders, PhD

    Chief Scientific Officer

    Mitchell Sanders MS, PhD, has over 30 years of experience in preclinical animal models and clinical product development in advanced wound care. With ECI Biotech, Mitchell has produced over 12 peer-reviewed publications and 27 worldwide patents in medical device and in vitro diagnostics. Mitchell is an expert in clinical and translational research and is a reviewer for the Wound Healing Society, CIMIT, MassVentures, MIT, WPI, Tech Sandbox, Piranha Pond, SBANE and the Venture Forum. Mitchell has an MS and PhD from WPI in molecular biology and biomedical sciences with 2 Postdocs (biochemistry and pathogen genetics) at the Whitehead Institute/MIT.